Good News for the Week

October 10, 2012 -- New Options for Patients with Brain Tumors; Increasing the Magnetic Pull of the Spine Center; ACC O-Arm; Visit to the North Carolina Eye Bank

 

Wu.jpg
Dr. Jing Wu
  • New Options for Patients with Brain Tumors: With Dr. Jing Wu as PI, the UNC Brain Tumor Program opened BTTC11-02, Vorinostat and Avastin for patients with recurrent malignant glioma, on October 2. This is an important clinical study for our patients with high-grade glioma and is the fourth protocol to open for brain tumor patients. This trial is opened through the Brain Tumor Trials Collaborative, of which UNC is a member.
Spine Center
Spine Center
  • Increasing the Magnetic Pull of the Spine Center: We’ve successfully installed MRI #2 at the Imaging & Spine Center and scanned our first patient on the new magnet on September 27. We look forward to being able to accommodate more outpatient MRIs at our facility. This should facilitate getting same-day MRIs for both spine and neurosurgery patients seen at the Spine Center Building.
News-O-arm Photo
O-arm
  • ACC O-Arm: Dr. Deb Bhowmick performed our first outpatient spine case at the Ambulatory Care Center (ACC) OR on October 1. Last Friday, he and the OR team did the first case with the new “O”-arm image guidance device.
Fowler, Craig
Dr. W. Craig Fowler
Pillsbury, Rick
Dr. Rick Pillsbury
Ewend.jpg
Dr. Matt Ewend
  • Visit to the North Carolina Eye Bank: Dr. W. Craig Fowler from the UNC Department of Ophthalmology, Dr. Rick Pillsbury from the Department of Otolaryngology (ENT) and Dr. Matthew G. Ewend from the Department of Neurosurgery, visited The North Carolina Eye Bank (NCEB) to tour their facilities and to give thanks to them for their founding gift for The North Carolina Eye Bank Surgical Skills Laboratory at UNC (aka the Skull Base Lab). As many of you are aware, The North Carolina Eye Bank made the founding gift of $1 million to support the lab.

    The tour of their facility in Winston-Salem was most impressive. They provide a vast majority of the corneal transplant tissue for all of North Carolina including those done at UNC and throughout the Triangle. They have developed new techniques for eye banking which are used the world over, have streamlined the process of getting high-quality specimens, and are widely regarded as one of, if not the premier, eye banks in the world.

    We’re very pleased to have this partnership with The North Carolina Eye Bank and hope that their participation in the Skills Lab will be only the first step in a growing relationship. Our thanks to Dean E. Vavra, MS, CEBT, Executive Director of NCEB, the members of the Board who met with us, and the entire staff, for their terrific support of the Skills Lab and for the outstanding work they do every day.

· New Options for Patients with Brain Tumors: With Dr. Jing Wu as PI, the UNC Brain Tumor Program opened BTTC11-02, Vorinostat and Avastin for patients with recurrent malignant glioma, on October 2. This is an important clinical study for our patients with high-grade glioma and is the fourth protocol to open for brain tumor patients. This trial is opened through the Brain Tumor Trials Collaborative, of which UNC is a member.